Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Boehringer Ingelheim

Last Updated: December 5, 2021

DrugPatentWatch Database Preview

Patent: 7,407,931

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 7,407,931
Title:Method of treating Crohn\'s Disease using sargramostim
Abstract: Immune stimulatory amounts of hematopoietic colony stimulating factors are administered to patients with inflammatory bowel disease. The factors include G-CSF and GM-CSF. These factors induce and maintain remission of the disease and its manifestations, whether within the intestine or without.
Inventor(s): Dieckgraefe; Brian K. (Chesterfield, MO), Korzenik; Joshua (St. Louis, MO)
Assignee: Washington University (St. Louis, MO)
Application Number:11/099,461
Patent Claims:see list of patent claims

Details for Patent 7,407,931

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Partner Therapeutics, Inc. LEUKINE sargramostim For Injection 103362 1991-03-05 ⤷  Try it Free 2020-02-11
Partner Therapeutics, Inc. LEUKINE sargramostim Injection 103362 1991-03-05 ⤷  Try it Free 2020-02-11
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.